CTKB Cytek BioSciences, Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Aurora and Northern Lights systems, are the first full spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells.

$18.93  -0.06 (-0.32%)
As of 12/06/2021 15:59:56 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  07/23/2021
Outstanding shares:  133,725,908
Average volume:  191,183
Market cap:   $2,606,317,947
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    23285D109
ISIN:        US23285D1090
Sedol:      BP0TJS2
Valuation   (See tab for details)
PE ratio:   694.99
PB ratio:   6.30
PS ratio:   21.78
Return on equity:   2.43%
Net income %:   8.18%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy